EIDX - エイドス・セラピュ―ティクス (Eidos Therapeutics Inc.) エイドス・セラピュ―ティクス

 EIDXのチャート


 EIDXの企業情報

symbol EIDx
会社名 Eidos Therapeutics Inc (エイドス・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 Eidos Therapeutics Inc. is a clinical stage biopharmaceutical company. The Company is focused on addressing the unmet need in diseases caused by transthyretin (TTR) amyloidosis (ATTR). It focuses on treating the disease by targeting them at their collective source by stabilizing TTR. The Company’s product candidate AG10 is an orally-administered small molecule designed to potently stabilize tetrameric TTR thereby halting at its outset the series of molecular events that give rise to ATTR. AG10 binds and stabilizes TTR in the blood preventing the formation of amyloid and halting progression of the disease.   エイドス・セラピュ―ティクスは米国のバイオ医薬品企業。臨床段階で、希少疾患に対する治療薬の開発・商業化に従事する。同社はトランスサイレチン(TTR)やアミドイロ―シス(ATTR)によって引き起こされる疾患に対する治療薬の開発に焦点を当てる。本社所在地はカリフォルニア州サンフランシスコ。   
本社所在地 101 Montgomery Street Suite 2550 San Francisco CA 94104 USA
代表者氏名 Jonathan C. Fox ジョナサン・フォックス
代表者役職名 President chief medical officer
電話番号 +1 650-391-9740
設立年月日 41487
市場名 NASDAQ National Market System
ipoyear 2018年
従業員数
url www.eidostx.com
nasdaq_url https://www.nasdaq.com/symbol/eidx
adr_tso
EBITDA EBITDA(百万ドル) -25.32500
終値(lastsale) 10.05
時価総額(marketcap) 369357871.35
時価総額 時価総額(百万ドル) 358.33220
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 181.64320
当期純利益 当期純利益(百万ドル) -34.08400
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Eidos Therapeutics Inc revenues was not reported. Net loss increased from $4.1M to $26.2M. Higher net loss reflects Research and development - Balan increase from $3.2M to $11.2M (expense) Loss on extinguishment of debt increase from $0K to $6.7M (expense) General and administrative increase from $831K to $3.9M (expense).

 EIDXのテクニカル分析


 EIDXのニュース

   Transthyretin Amyloidosis Treatment Market - Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc., GlaxoSmithKline Plc., Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation Biotech, S.L.  2021/03/08 06:30:34 OpenPR
Transthyretin Amyloidosis Treatment Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Transthyretin Amyloidosis Treatment industry overview and then goes into each and every detail. Transthyretin Amyloidosis Treatment Market Report contains in depth
   Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger  2021/01/04 12:30:00 GlobeNewswire
PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional…
   SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX  2020/12/19 21:17:00 Benzinga
NEW YORK , Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Standard AVB Financial Corp. (NASDAQ: STND ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click here to learn more about your legal rights and options . Eidos Therapeutics, Inc. (NASDAQ: EIDX ) concerning potential violations of the federal securities laws and/or … Full story available on Benzinga.com
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback  2020/11/25 12:35:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) AbbVie Inc (NYSE: ABBV ) Affimed NV (NASDAQ: AFMD ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cellectis SA (NASDAQ: CLLS ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Generation Bio Co (NASDAQ: GBIO ) Inspire Medical Systems Inc (NYSE: INSP ) Kronos Bio Inc (NASDAQ: KRON ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) NeoGenomics, Inc. (NASDAQ: NEO ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pulmonx Corp (NASDAQ: LUNG ) Relay Therapeutics Inc (NASDAQ: RLAY ) Sotera Health Co (NASDAQ: SHC ) (began trading on Nasdaq Friday following its IPO) Trinity Biotech plc (NASDAQ: TRIB ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 24) Advaxis, Inc. (NASDAQ: ADXS ) ( announced a public offering of common stock and warrants) Immunome Inc (NASDAQ: IMNM ) InMed Pharmaceuticals Inc (NASDAQ: INM ) Kiromic Biopharma Inc (NASDAQ: KRBP ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI ) debuted on Wall Street Friday) Qualigen …
   Transthyretin Amyloidosis Treatment Market - Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc., GlaxoSmithKline Plc., Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation Biotech, S.L.  2021/03/08 06:30:34 OpenPR
Transthyretin Amyloidosis Treatment Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Transthyretin Amyloidosis Treatment industry overview and then goes into each and every detail. Transthyretin Amyloidosis Treatment Market Report contains in depth
   Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger  2021/01/04 12:30:00 GlobeNewswire
PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional…
   SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX  2020/12/19 21:17:00 Benzinga
NEW YORK , Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Standard AVB Financial Corp. (NASDAQ: STND ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click here to learn more about your legal rights and options . Eidos Therapeutics, Inc. (NASDAQ: EIDX ) concerning potential violations of the federal securities laws and/or … Full story available on Benzinga.com
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback  2020/11/25 12:35:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) AbbVie Inc (NYSE: ABBV ) Affimed NV (NASDAQ: AFMD ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cellectis SA (NASDAQ: CLLS ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Generation Bio Co (NASDAQ: GBIO ) Inspire Medical Systems Inc (NYSE: INSP ) Kronos Bio Inc (NASDAQ: KRON ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) NeoGenomics, Inc. (NASDAQ: NEO ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pulmonx Corp (NASDAQ: LUNG ) Relay Therapeutics Inc (NASDAQ: RLAY ) Sotera Health Co (NASDAQ: SHC ) (began trading on Nasdaq Friday following its IPO) Trinity Biotech plc (NASDAQ: TRIB ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 24) Advaxis, Inc. (NASDAQ: ADXS ) ( announced a public offering of common stock and warrants) Immunome Inc (NASDAQ: IMNM ) InMed Pharmaceuticals Inc (NASDAQ: INM ) Kiromic Biopharma Inc (NASDAQ: KRBP ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI ) debuted on Wall Street Friday) Qualigen …
   Transthyretin Amyloidosis Treatment Market - Alnylam Pharmaceuticals, Inc., Pfizer, Inc., Prothena Corporation Plc., GlaxoSmithKline Plc., Ionis Pharmaceuticals, Inc., Eidos Therapeutics, and SOM Innovation Biotech, S.L.  2021/03/08 06:30:34 OpenPR
Transthyretin Amyloidosis Treatment Market Report 2020-2027 includes a comprehensive analysis of the present Market. The report starts with the basic Transthyretin Amyloidosis Treatment industry overview and then goes into each and every detail. Transthyretin Amyloidosis Treatment Market Report contains in depth
   Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed Merger  2021/01/04 12:30:00 GlobeNewswire
PALO ALTO, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced that leading proxy advisory firm Institutional…
   SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - STND, EIDX, WTRE, ARA, CGIX  2020/12/19 21:17:00 Benzinga
NEW YORK , Dec. 19, 2020 /PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Standard AVB Financial Corp. (NASDAQ: STND ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Dollar Mutual Bancorp for $33.00 per share. If you are a Standard AVB shareholder, click here to learn more about your legal rights and options . Eidos Therapeutics, Inc. (NASDAQ: EIDX ) concerning potential violations of the federal securities laws and/or … Full story available on Benzinga.com
   The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Gets Temporary UK Authorization, Ovid's Trial Disappointment, Vanda Snags FDA Nod  2020/12/02 12:35:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 1) AbbVie Inc (NYSE: ABBV ) Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT ) argenx SE – ADR (NASDAQ: ARGX ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) Auris Medical Holding Ltd (NASDAQ: EARS ) (announced positive efficacy data from lab testing of AM-301 against airborne pathogens and allergens, including SARS-CoV-2) Beam Therapeutics Inc (NASDAQ: BEAM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) BioNTech SE – ADR (NASDAQ: BNTX ) BioTelemetry Inc (NASDAQ: BEAT ) Blueprint Medicines Corp (NASDAQ: BPMC ) BridgeBio Pharma Inc (NASDAQ: BBIO ) (announced FDA acceptance of NDA for infigratinib for individuals with cancer of the bile ducts) Cardiff Oncology Inc (NASDAQ: CRDF ) Cellectis SA (NASDAQ: CLLS ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Codiak BioSciences Inc (NASDAQ: CDAK ) strong>Crispr Therapeutics AG (NASDAQ: CRSP ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Foghorn Therapeutics Inc.
   The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback  2020/11/25 12:35:38 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 24) AbbVie Inc (NYSE: ABBV ) Affimed NV (NASDAQ: AFMD ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Atea Pharmaceuticals, Inc. (NASDAQ: AVIR ) C4 Therapeutics Inc (NASDAQ: CCCC ) Cardiff Oncology Inc (NASDAQ: CRDF ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) Cellectis SA (NASDAQ: CLLS ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Generation Bio Co (NASDAQ: GBIO ) Inspire Medical Systems Inc (NYSE: INSP ) Kronos Bio Inc (NASDAQ: KRON ) Merit Medical Systems, Inc. (NASDAQ: MMSI ) NeoGenomics, Inc. (NASDAQ: NEO ) NGM Biopharmaceuticals Inc (NASDAQ: NGM ) Nurix Therapeutics Inc (NASDAQ: NRIX ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Pulmonx Corp (NASDAQ: LUNG ) Relay Therapeutics Inc (NASDAQ: RLAY ) Sotera Health Co (NASDAQ: SHC ) (began trading on Nasdaq Friday following its IPO) Trinity Biotech plc (NASDAQ: TRIB ) Veracyte Inc (NASDAQ: VCYT ) Zai Lab Ltd – ADR (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 24) Advaxis, Inc. (NASDAQ: ADXS ) ( announced a public offering of common stock and warrants) Immunome Inc (NASDAQ: IMNM ) InMed Pharmaceuticals Inc (NASDAQ: INM ) Kiromic Biopharma Inc (NASDAQ: KRBP ) Maravai Lifesciences Holdings Inc (NASDAQ: MRVI ) debuted on Wall Street Friday) Qualigen …

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 エイドス・セラピュ―ティクス EIDX Eidos Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)